Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone and dexmedetomidine as adjuvants for interscalene brachial plexus block
ChiCTR2300077921Phase 4Recruiting
- Sponsor
- Wuxi Xishan People's Hospital
- Start
- Dec 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone, dexmedetomidine and ropivacaine in postoperative pain (4 arms), sponsored by Wuxi Xishan People's Hospital. Primary endpoint: duration of analgesia. Started Dec 2023; status: recruiting.
02
Drugs
dexamethasonedexmedetomidineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300077921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077921.